Abeona Therapeutics Inc (ABEO):企業の財務・戦略的SWOT分析

◆英語タイトル:Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH55346FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Abeona Therapeutics Inc (ABEO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associated virus. Abeona also develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-202 (AAV-CLN1) gene therapy for treatment of infantile Batten disease (INCL), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL) and more. The company has partnerships for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in New York City, the US.

Abeona Therapeutics Inc Key Recent Developments

Mar 25,2021: Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Mar 24,2021: Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Mar 22,2021: Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
Feb 22,2021: Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09,2020: Abeona Therapeutics reports third quarter financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Abeona Therapeutics Inc – Key Facts
Abeona Therapeutics Inc – Key Employees
Abeona Therapeutics Inc – Key Employee Biographies
Abeona Therapeutics Inc – Major Products and Services
Abeona Therapeutics Inc – History
Abeona Therapeutics Inc – Company Statement
Abeona Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Abeona Therapeutics Inc – Business Description
Abeona Therapeutics Inc – Corporate Strategy
Abeona Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Abeona Therapeutics Inc – Strengths
Abeona Therapeutics Inc – Weaknesses
Abeona Therapeutics Inc – Opportunities
Abeona Therapeutics Inc – Threats
Abeona Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abeona Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 25, 2021: Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Mar 24, 2021: Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Mar 22, 2021: Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
Feb 22, 2021: Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09, 2020: Abeona Therapeutics reports third quarter financial results
Oct 27, 2020: Abeona Therapeutics announces the appointment of Michael Amoroso as Chief Operating Officer
Oct 06, 2020: Abeona Therapeutics’ Board of Directors forms special committee to oversee operations, develop strategic direction and leadership plan
Sep 28, 2020: Abeona Therapeutics announces leadership and board transitions
Aug 10, 2020: Abeona Therapeutics reports second quarter financial results and business updates
Jul 09, 2020: Abeona Therapeutics announces appointment of Michael Amoroso as Chief Commercial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Abeona Therapeutics Inc, Key Facts
Abeona Therapeutics Inc, Key Employees
Abeona Therapeutics Inc, Key Employee Biographies
Abeona Therapeutics Inc, Major Products and Services
Abeona Therapeutics Inc, History
Abeona Therapeutics Inc, Subsidiaries
Abeona Therapeutics Inc, Key Competitors
Abeona Therapeutics Inc, Annual Ratios
Abeona Therapeutics Inc, Annual Ratios (Cont...1)
Abeona Therapeutics Inc, Interim Ratios
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abeona Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Abeona Therapeutics Inc (ABEO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perdana Petroleum Bhd (PERDANA):企業の財務・戦略的SWOT分析
    Perdana Petroleum Bhd (PERDANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), formerly Midelfart Sonesson AB is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food …
  • Orliman SLU:医療機器:M&Aディール及び事業提携情報
    Summary Orliman SLU (Orliman), a subsidiary of The Riverside Company, is a medical device company that develops and manufactures orthopedic products. The company provides products such as stabilizers, immobilizers, lumbosacral back supports, abdominal bands, abdominal belt, shoulder supports, truss, …
  • Sectra AB (SECT B)
    Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Rich Pharmaceuticals Inc (RCHA)-製薬・医療分野:企業M&A・提携分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of cancer and neurological disorders. The company’s pipeline portfolio offers a lead drug candidate for the treatment of acute myeloid leukemia …
  • Axalta Coating Systems Ltd:企業の戦略・SWOT・財務情報
    Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Famous Brands Limited (Foodservice):企業の戦略・SWOT・財務情報
    Famous Brands Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Famous Brands Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • CJ ENM Co Ltd (035760):企業の財務・戦略的SWOT分析
    CJ ENM Co Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Intersect ENT Inc (XENT)-医療機器分野:企業M&A・提携分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that provides chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Interse …
  • Stresau Laboratory, Inc.:企業の戦略・SWOT・財務情報
    Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Medrobotics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Vodacom Group Ltd (VOD):企業の財務・戦略的SWOT分析
    Vodacom Group Ltd (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bilfinger Tebodin B.V.:企業の戦略的SWOT分析
    Bilfinger Tebodin B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SMA Solar Technology AG (S92):電力:M&Aディール及び事業提携情報
    Summary SMA Solar Technology AG (SMA) is a renewable energy company. It develops, produces, and distributes photovoltaic inverters, choke coils, transformers, and monitoring and energy management systems for PV systems. The company also offers intelligent energy management solutions and digital serv …
  • Teekay Corp (TK):石油・ガス:M&Aディール及び事業提携情報
    Summary Teekay Corp (Teekay) is a provider of marine transportation services to oil and gas industry. The company transports crude oil, liquefied natural gas (LNG), liquefied petroleum gas (LPG) and other petroleum products. It also offers offshore oil production, storage and offloading services. Te …
  • Boralex Inc:発電所・企業SWOT分析
    Boralex Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Dana Brevini Spa:企業の戦略・SWOT・財務分析
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Amicus Therapeutics Inc (FOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lea …
  • Black Hills Corporation (BKH)-エネルギー分野:企業M&A・提携分析
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Siemens AG (SIE):医療機器:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆